Form 4: CoreWeave CDO Sells 27,000 Shares via Pre-Arranged Plan

CoreWeave's Chief Development Officer, Brannin McBee, reported the sale of 27,000 Class A Common Stock shares on January 5, 2026, through pre-arranged Rule 10b5-1 trading plans.

Summary

• Brannin McBee, CoreWeave's Chief Development Officer, reported transactions involving the company's Class A and Class B Common Stock.
• On January 5, 2026, 27,000 shares of Class B Common Stock were converted into Class A Common Stock.
• Immediately following conversion, 27,000 shares of Class A Common Stock were sold across multiple transactions.
• These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by McBee on September 2, 2025.
• The sales were conducted through three entities: Canis Major 2025 Family Trust LLC (1,000 shares), Canis Minor 2025 Family Trust LLC (1,000 shares), and Canis Major 2025 GRAT (25,000 shares).
• Weighted average sale prices for Class A Common Stock ranged from $76.82 to $84.27 per share.
• Following these transactions, McBee, through the Canis Major 2025 Family Trust LLC, indirectly beneficially owns 114,600 shares of Class B Common Stock.
• Through the Canis Minor 2025 Family Trust LLC, McBee indirectly beneficially owns 128,000 shares of Class B Common Stock.
• Through the Canis Major 2025 GRAT, McBee indirectly beneficially owns 5,850,000 shares of Class B Common Stock.
• This Form 4 represents Part 2 of 3 for this reporting person, indicating further transactions will be reported.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can be perceived negatively, the pre-arranged nature of the Rule 10b5-1 plan mitigates concerns that the sales are based on new, non-public negative information. It is a routine disclosure of a planned transaction.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which provides an affirmative defense against insider trading allegations by scheduling transactions in advance.

Negatives

• The sale of a significant number of shares (27,000) by a Chief Development Officer could be perceived negatively by investors, potentially signaling a lack of confidence, despite being pre-planned.

Risks

• Insider selling, even when pre-planned, can sometimes lead to negative market sentiment or speculation regarding the company's future prospects.
• The filing explicitly states this is 'Part 2 of 3' for the reporting person, indicating that additional insider transactions will be disclosed, which could further impact market perception.

Future Outlook

This filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

Industry Context

This insider transaction report does not provide information directly related to broader industry trends or competitive landscape.

Corporate Governance

Related Party Transactions

• The reported securities are indirectly held and transacted through the Canis Major 2025 Family Trust LLC, Canis Minor 2025 Family Trust LLC, and Canis Major 2025 GRAT, for which the reporting person serves as manager, sole trustee, and beneficiary, respectively.

Stakeholder Impact

• Shareholders may interpret the insider selling as a signal, though the 10b5-1 plan suggests it is not based on new, adverse information.
• The transparency provided by the Form 4 filing helps maintain investor confidence in fair market practices.

Next Steps

• Further transactions by this reporting person are expected to be disclosed, as this filing is noted as 'Part 2 of 3'.

Key Dates

Keywords

CoreWeave, CRWV, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Brannin McBee, Chief Development Officer, Equity Transaction